Arrowhead Pharmaceuticals Inc. buy Chardan Capital
Start price
10.05.24
/
50%
€20.70
Target price
10.05.25
€55.70
Performance (%)
-17.54%
Price
03.10.24
€17.07
Summary
This prediction is currently active. The prediction for Arrowhead Pharmaceuticals Inc. disappoints with a performance of -17.54%. This prediction currently runs until 10.05.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arrowhead Pharmaceuticals Inc. | -3.149% | -3.149% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Chardan_Capital for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $60.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Chardan_Capital for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.45
18.07.24
18.07.24
€54.83
18.07.25
18.07.25
-32.93%
03.10.24
03.10.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.45
18.07.24
18.07.24
€54.83
18.07.25
18.07.25
-32.93%
03.10.24
03.10.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.44
26.06.24
26.06.24
€56.18
26.06.25
26.06.25
-32.90%
03.10.24
03.10.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€22.62
03.06.24
03.06.24
€55.13
03.06.25
03.06.25
-24.54%
03.10.24
03.10.24
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.07
08.08.23
08.08.23
€54.73
08.08.24
08.08.24
-10.25%
09.08.24
09.08.24